SARS-CoV-2 Nucleocapsid Protein

<strong>SARS-CoV-2 Nucleocapsid Protein</strong>_x000D_ <strong>Catalog number:</strong> B2010497_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 47 kDa_x000D_ <strong>Supplied as:</strong> Lyophilized Powder_x000D_ <strong>Applications:</strong> molecular component of serological and antigenic assays for SARS-CoV-2_x000D_ <strong>Storage:</strong> -20℃_x000D_ <strong>Keywords:</strong> Nucleoprotein, N protein_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2022/03/MKT-010-SARS-CoV-2-Brochure-Rev-A.pdf"><strong>Download SARS-CoV-2 Brochure</strong></a>_x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Malik YA. Properties of Coronavirus and SARS-CoV-2. Malays J Pathol. 2020_x000D_ Apr;42(1):3-11._x000D_ 2: Wang H, Li X, Li T, Zhang S, Wang L, Wu X, Liu J. The genetic sequence,_x000D_ origin, and diagnosis of SARS-CoV-2. Eur J Clin Microbiol Infect Dis. 2020_x000D_ Sep;39(9):1629-1635._x000D_ _x000D_ 3: Zeng W, Liu G, Ma H, Zhao D, Yang Y, Liu M, Mohammed A, Zhao C, Yang Y, Xie_x000D_ J, Ding C, Ma X, Weng J, Gao Y, He H, Jin T. Biochemical characterization of_x000D_ SARS-CoV-2 nucleocapsid protein. Biochem Biophys Res Commun. 2020 Jun_x000D_ 30;527(3):618-623._x000D_ _x000D_ 4: Le Bert N, Tan AT, Kunasegaran K, Tham CYL, Hafezi M, Chia A, Chng MHY, Lin_x000D_ M, Tan N, Linster M, Chia WN, Chen MI, Wang LF, Ooi EE, Kalimuddin S, Tambyah_x000D_ PA, Low JG, Tan YJ, Bertoletti A. SARS-CoV-2-specific T cell immunity in cases_x000D_ of COVID-19 and SARS, and uninfected controls. Nature. 2020_x000D_ Aug;584(7821):457-462._x000D_ _x000D_ 5: Hasöksüz M, Kiliç S, Saraç F. Coronaviruses and SARS-COV-2. Turk J Med Sci._x000D_ 2020 Apr 21;50(SI-1):549-556._x000D_ _x000D_ 6: Ye Q, West AMV, Silletti S, Corbett KD. Architecture and self-assembly of the_x000D_ SARS-CoV-2 nucleocapsid protein. Protein Sci. 2020 Sep;29(9):1890-1901._x000D_ _x000D_ 7: Perdikari TM, Murthy AC, Ryan VH, Watters S, Naik MT, Fawzi NL. SARS-CoV-2_x000D_ nucleocapsid protein phase-separates with RNA and with human hnRNPs. EMBO J._x000D_ 2020 Dec 15;39(24):e106478._x000D_ _x000D_ 8: Sun B, Feng Y, Mo X, Zheng P, Wang Q, Li P, Peng P, Liu X, Chen Z, Huang H,_x000D_ Zhang F, Luo W, Niu X, Hu P, Wang L, Peng H, Huang Z, Feng L, Li F, Zhang F, Li_x000D_ F, Zhong N, Chen L. Kinetics of SARS-CoV-2 specific IgM and IgG responses in_x000D_ COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):940-948._x000D_ _x000D_ 9: Savastano A, Ibáñez de Opakua A, Rankovic M, Zweckstetter M. Nucleocapsid_x000D_ protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing_x000D_ condensates. Nat Commun. 2020 Nov 27;11(1):6041._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33031947/">10: Diao B, Wen K, Zhang J, Chen J, Han C, Chen Y, Wang S, Deng G, Zhou H, Wu Y._x000D_ Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-_x000D_ CoV-2 infection. Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4.</a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 Nucleocapsid Protein</strong> <a href="https://moleculardepot.com/product-category/SARS-CoV-2/">: SARS-CoV-2</a>